FI962440A - Vitamiini D:n amiini- ja amidijohdoksia - Google Patents

Vitamiini D:n amiini- ja amidijohdoksia Download PDF

Info

Publication number
FI962440A
FI962440A FI962440A FI962440A FI962440A FI 962440 A FI962440 A FI 962440A FI 962440 A FI962440 A FI 962440A FI 962440 A FI962440 A FI 962440A FI 962440 A FI962440 A FI 962440A
Authority
FI
Finland
Prior art keywords
group
formula
pct
vitamin
compound
Prior art date
Application number
FI962440A
Other languages
English (en)
Swedish (sv)
Other versions
FI962440A0 (fi
FI112360B (fi
Inventor
Robert Henry Hesse
Malathi Ramgopal
Sundara Katugam Srinivas Setty
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Publication of FI962440A0 publication Critical patent/FI962440A0/fi
Publication of FI962440A publication Critical patent/FI962440A/fi
Application granted granted Critical
Publication of FI112360B publication Critical patent/FI112360B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962440A 1993-12-13 1996-06-12 Menetelmä terapeuttisesti käyttökelpoisten vitamiini D:n amiini- ja amidijohdannaisten valmistamiseksi FI112360B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939325415A GB9325415D0 (en) 1993-12-13 1993-12-13 Chemical compounds
GB9325415 1993-12-13
GB9402725 1994-12-13
PCT/GB1994/002725 WO1995016672A1 (en) 1993-12-13 1994-12-13 Vitamin d amine and amide derivatives

Publications (3)

Publication Number Publication Date
FI962440A0 FI962440A0 (fi) 1996-06-12
FI962440A true FI962440A (fi) 1996-06-12
FI112360B FI112360B (fi) 2003-11-28

Family

ID=10746493

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962440A FI112360B (fi) 1993-12-13 1996-06-12 Menetelmä terapeuttisesti käyttökelpoisten vitamiini D:n amiini- ja amidijohdannaisten valmistamiseksi

Country Status (22)

Country Link
US (1) US5786347A (fi)
EP (1) EP0734376B1 (fi)
JP (1) JP3779991B2 (fi)
KR (1) KR100399661B1 (fi)
CN (1) CN1080718C (fi)
AT (1) ATE196468T1 (fi)
AU (1) AU681223B2 (fi)
CA (1) CA2178090A1 (fi)
CZ (1) CZ291623B6 (fi)
DE (1) DE69425980T2 (fi)
DK (1) DK0734376T3 (fi)
ES (1) ES2149957T3 (fi)
FI (1) FI112360B (fi)
GB (1) GB9325415D0 (fi)
GR (1) GR3035028T3 (fi)
HU (1) HU223469B1 (fi)
IL (1) IL111975A (fi)
NO (1) NO313800B1 (fi)
NZ (1) NZ277086A (fi)
PT (1) PT734376E (fi)
WO (1) WO1995016672A1 (fi)
ZA (1) ZA949921B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
EP1011683A4 (en) * 1997-05-22 2003-06-11 Cephalon Inc VITAMIN D ANALOGS AND THEIR EFFECTS ON NEURONS
US6043385A (en) * 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
AU9654201A (en) 2000-10-02 2002-04-15 Univ Emory Triptolide analogs for the treatment of autoimmune and inflammatory disorders
WO2005027928A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs
CN107019795A (zh) * 2009-01-27 2017-08-08 博格有限责任公司 用于减轻与化疗有关的副作用的维生素d3化合物
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
WO2012158794A1 (en) 2011-05-17 2012-11-22 Wisconsin Alumni Research Foundation N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
US8785603B2 (en) 2011-05-20 2014-07-22 Siemens Healthcare Diagnostics Inc. Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
US9244083B2 (en) 2012-11-30 2016-01-26 Siemens Healthcare Diagnostics Inc. Compositions and methods for detecting vitamin D
US9618523B2 (en) 2013-02-28 2017-04-11 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes
NZ714801A (en) 2013-05-29 2021-07-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664213B2 (en) * 1991-11-07 1995-11-09 Research Institute For Medicine And Chemistry Inc. Vitamin D amide derivatives
JPH06107625A (ja) * 1992-01-13 1994-04-19 Asahi Chem Ind Co Ltd 新規な１α、２５−ジヒドロキシビタミンＤ誘導体、およびその製造法

Also Published As

Publication number Publication date
CZ291623B6 (cs) 2003-04-16
ZA949921B (en) 1995-10-12
ATE196468T1 (de) 2000-10-15
JP3779991B2 (ja) 2006-05-31
US5786347A (en) 1998-07-28
FI962440A0 (fi) 1996-06-12
WO1995016672A1 (en) 1995-06-22
NO313800B1 (no) 2002-12-02
AU681223B2 (en) 1997-08-21
EP0734376B1 (en) 2000-09-20
IL111975A (en) 1999-07-14
JPH09511224A (ja) 1997-11-11
DE69425980T2 (de) 2001-02-08
AU1215895A (en) 1995-07-03
NO962479L (no) 1996-08-12
CA2178090A1 (en) 1995-06-22
HU9601622D0 (en) 1996-08-28
CN1141625A (zh) 1997-01-29
DK0734376T3 (da) 2000-12-11
GR3035028T3 (en) 2001-03-30
NZ277086A (en) 1997-04-24
HU223469B1 (hu) 2004-07-28
ES2149957T3 (es) 2000-11-16
CZ170496A3 (en) 1997-02-12
FI112360B (fi) 2003-11-28
PT734376E (pt) 2000-12-29
KR100399661B1 (ko) 2004-04-30
EP0734376A1 (en) 1996-10-02
GB9325415D0 (en) 1994-02-16
DE69425980D1 (de) 2000-10-26
CN1080718C (zh) 2002-03-13
NO962479D0 (no) 1996-06-12
HUT75515A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
ATE196468T1 (de) Vitamin d amin- und amidderivate
FI955316A (fi) Vitamiini D:n amidijohdannaisia
CA2143636A1 (en) Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
ATE243688T1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69414115D1 (de) Vitamin d analoge
AU1956095A (en) Vitamin-d amide derivatives
ATE401303T1 (de) Verfahren zur herstellung von ed-71
KR960010739A (ko) 암모늄염을 함유하는 예비 중합체 및 이의 제조방법

Legal Events

Date Code Title Description
MA Patent expired